Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advantage Solutions A | ADV | Sep 4, 2024 | 3.84 | +2.67 |
Advent | AVK | Sep 4, 2024 | 12.52 | -1.03 |
Advent Technologies A | ADN | Sep 4, 2024 | 2.58 | +3.23 |
Adverum Biotechnologies | ADVM | Sep 4, 2024 | 6.77 | +0.15 |
AdvisorShares Pure US Cannabis ETF | MSOS | Sep 4, 2024 | 6.48 | -0.31 |
Advisorshares Star Global Buy-Write ETF | VEGA | Sep 4, 2024 | 42.88 | -0.14 |
AECOM | ACM | Sep 4, 2024 | 96.43 | -1.21 |
Aegon N.V ADR | AEG | Sep 4, 2024 | 6.03 | +0.50 |
Aehr Test Systems | AEHR | Sep 4, 2024 | 13.11 | -2.96 |
Aemetis | AMTX | Sep 4, 2024 | 2.26 | -0.88 |
Aeon Biopharma | AEON | Sep 4, 2024 | 0.83 | -1.48 |
AerCap Holdings | AER | Sep 4, 2024 | 92.95 | +0.56 |
Aeries Technology | AERT | Sep 4, 2024 | 1.80 | -4.00 |
Aerospace & Defense Powershares | PPA | Sep 4, 2024 | 110.54 | +0.38 |
Aerovate Therapeutics | AVTE | Sep 4, 2024 | 1.90 | +2.15 |
AeroVironment | AVAV | Sep 4, 2024 | 194.04 | +0.93 |
AerSale | ASLE | Sep 4, 2024 | 4.74 | -1.04 |
AES | AES | Sep 4, 2024 | 16.94 | +1.13 |
Aetherium Acquisition A | GMFI | Sep 4, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Sep 4, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Sep 4, 2024 | 0.34 | -2.45 |
Aeva Technologies | AEVA | Sep 4, 2024 | 2.52 | -8.70 |
AEye A | LIDR | Sep 4, 2024 | 1.13 | -5.04 |
AFC Gamma | AFCG | Sep 4, 2024 | 10.24 | -1.35 |
Affiliated Managers Group | AMG | Sep 4, 2024 | 169.43 | -0.73 |
Affimed N.V. | AFMD | Sep 4, 2024 | 3.75 | -5.06 |
Affinity Bancshares | AFBI | Sep 4, 2024 | 21.34 | 0.00 |
Affirm A | AFRM | Sep 4, 2024 | 40.23 | -3.27 |
Aflac | AFL | Sep 4, 2024 | 110.49 | +1.30 |
Africa Index ETF Market Vectors | AFK | Sep 4, 2024 | 15.75 | +0.83 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.